“We are grateful to have experts from various backgrounds, such us startups, corporations and international academia, to guide and support the functions and development of the center,” says Michael Hummel, the Director of Bioinnovation Center. The external advisors are Suvi Haimi (CEO, Sulapac), Elvin Karana (Prof., TU Delft), Niklas von Weymarn (CEO, Metsä Spring), Tuomas Mustonen (CEO, Paptic), and Riikka Paarma (Sustainability Partner, EY Parthenon).
The discussion revolved around opportunities for academic institutes to support industrial R&D in the field of bioproduct development. The need for specialist analytics (especially new methods), limited time resources to understand the scientific phenomena, and necessity to stay close to the core topics instead of exploring disruptive new ideas were identified as prevalent challenges. When building a research collaboration with companies, it is important to align the resources of the company, the timeline, and the problem statement. These three must fit together to make a successful collaboration.
Concerning the target groups for the center’s dissemination and outreach activities, the advisory board found it important that the Bioinnovation Center keeps its neutral expert status in focus: a discussion forum and a local voice of aspects associated to Bioinnovation, also in the context of legislation and regulations. “Although companies might be competitors, we should find ways whenever possible to collaborate. We all are needed to reduce society’s dependence on fossil raw materials and to protect biodiversity. I see an opportunity for the Bioinnovation Center to facilitate this,” stated Suvi Haimi, the CEO of Sulapac.